A dual PI3 kinase/mTOR inhibitor reveals emergent efficacy in glioma
Qi-Wen Fan(City College of San Francisco), William A. Weiss(City College of San Francisco), Keith E. Mostov(Rockefeller University), Zachary A. Knight(Howard Hughes Medical Institute), David Stokoe(Enzo Life Sciences (United States)), Wei Yu(Rutgers, The State University of New Jersey), Kevan M. Shokat(Howard Hughes Medical Institute), David Goldenberg(Pennsylvania State University)
Cited by 584
Related Papers
K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions
|Nature|2013|2.5k
RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF
|Nature|2010|1.8k
Molecular Determinants of the Response of Glioblastomas to EGFR Kinase Inhibitors
|New England Journal of Medicine|2005|1.4k
IRE1 Signaling Affects Cell Fate During the Unfolded Protein Response
|Science|2007|1.4k